Financial reports
20-F
2021 FY
Annual report (foreign)
8 Apr 22
20-F
2020 FY
Annual report (foreign)
14 Apr 21
20-F
2019 FY
Annual report (foreign)
24 Apr 20
20-F
2018 FY
Annual report (foreign)
4 Apr 19
20-F
2017 FY
Annual report (foreign)
30 Apr 18
20-F
2016 FY
Annual report (foreign)
18 Apr 17
20-F
2015 FY
Annual report (foreign)
12 Apr 16
20-F
2014 FY
Annual report (foreign)
25 Mar 15
Current reports
6-K
Current report (foreign)
13 Jan 23
6-K
Current report (foreign)
28 Dec 22
6-K
Current report (foreign)
19 Dec 22
6-K
Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for Review
6 Dec 22
6-K
Current report (foreign)
21 Nov 22
6-K
Unaudited Interim Condensed Consolidated Financial Statements
9 Nov 22
6-K
Current report (foreign)
12 Sep 22
6-K
Current report (foreign)
7 Jul 22
6-K
Current report (foreign)
20 May 22
6-K
Current report (foreign)
5 May 22
Registration and prospectus
POS AM
Prospectus update (post-effective amendment)
20 Jan 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Jan 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Jan 23
15-12G
Securities registration termination
17 Jan 23
25-NSE
Exchange delisting
6 Jan 23
F-3
Shelf registration (foreign)
13 Dec 21
S-8
Registration of securities for employees
13 Dec 21
S-8
Registration of securities for employees
9 Apr 15
424B4
Prospectus supplement with pricing info
15 Oct 14
F-1MEF
Registration statement to add securities to prior F-1 registration
15 Oct 14
Proxies
No filings
Other
EFFECT
Notice of effectiveness
24 Jan 23
EFFECT
Notice of effectiveness
27 Dec 21
CORRESP
Correspondence with SEC
21 Dec 21
UPLOAD
Letter from SEC
16 Dec 21
EFFECT
Notice of effectiveness
16 Oct 14
EFFECT
Notice of effectiveness
14 Oct 14
CORRESP
Correspondence with SEC
10 Oct 14
CORRESP
Correspondence with SEC
10 Oct 14
CORRESP
Correspondence with SEC
9 Oct 14
UPLOAD
Letter from SEC
8 Oct 14
Ownership
SC 13G/A
Rosetta Capital I, LP
14 Feb 23
SC 13G
StepStone Group LP
29 Dec 22
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
14 Feb 22
SC 13G/A
Newtyn Management, LLC
16 Feb 21
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
11 Feb 21
SC 13G/A
Beneficial ownership report (amended)
14 Feb 20
SC 13G
Forward Pharma A/S
14 Feb 20
SC 13G/A
Forward Pharma A/S
14 Feb 19
SC 13G/A
Forward Pharma A/S
4 May 18
SC 13G/A
Forward Pharma A/S
9 Feb 18